Venous Thromboembolism (vte)

ثبت نشده
چکیده

Epidemiology (CDC, Beckman, Am J Prev Med, 2010) ●Includes deep venous thrombosis (DVT) and pulmonary embolism (PE) and affects more than 300,000 to 600,000 patients annually with 60,000-100,000 deaths (some estimates as high as 300,000); AHRQ estimates 2 million affected per year and 200,000 deaths; 50% develop during admission or within 30 days after hospitalization ●PE remains most common preventable cause of in-hospital mortality and a leading cause of maternal mortality in the U.S.; fatal PE is the 3rd most common cause of death in trauma patients who survive the first 24 hours ●Incidence of 1-2/1000 of general population; as high as 1/100 in those >80 years of age; likelihood of developing a VTE doubles with each decade of life after 40 ●2/3rd of VTE present as DVT, 1/3rd PE (+/DVT); 50% are idiopathic; 60% are occult; sudden death is the first symptom in 25% of people who have a PE; in fatal PE, 2/3rd die within 1 hour; 10 to 30% of people will die within one month of diagnosis; 1/3rd of people with DVT/PE will have a recurrence within 10 years ◊3 month mortality 17% increased to 31% to 52% if associated with hemodyamic instability; PE contributed to cause of death in 63-91% (MAPPET and ICOPER studies) ●Outcome of PE dependent on size of embolus and patient’s underlying cardiopulmonary status ●Among people who have had a DVT, 1/3 develop post-thrombotic syndrome ●Approximately 5 to 8 percent of the U.S. population has one of several genetic risk factors in which a genetic defect can be identified that increases the risk for thrombosis ●20% of calf DVTs propagate to thigh; 50% of proximal DVTs embolize to the lungs; 90% of PEs come from lower extremity DVTs) ●Autopsy studies in trauma patients – 65% incidence of DVT and 16% PE (Sevitt, BMJ, 1961) ●Autopsy studies in critically ill patients find that PE was cause of death in 45% of patients and was not suspected ●Incidence in the absence of (appropriate) prophylaxis ◊General surgery – 20-30% incidence of DVT, proximal 7%, fatal PE 0.1 to 0.8% (18% if untreated) ◊Trauma – 58% incidence of DVT, proximal DVT 18%, PE in 2-22%, fatal PE 1% (Geerts, NEJM, 1994) ◊Fractured hip – 50% incidence of DVT, proximal DVT 20%, 4 to 7% risk of fatal PE ◊SCI – 90% incidence of DVT ◊Medical ▪DVT FREE Registry Study – 50% of inpatients who developed VTE were nonsurgical ▪ 17-34% MI, 20-40% CHF, 11-75% stroke, 25-42% MICU ●Numerous initiatives to increase prophylaxis ◊Thrombophylaxis not being offered (or not appropriate method) despite numerous guidelines – only 60% of at-risk surgical patients received American College of Chest Physicians (ACCP)-recommended prophylaxis (ENDORSE Study) ◊Agency for Health Care Research and Quality (AHRQ) #1 strategy to improve patient safety in hospitals is prevention of VTE ◊Surgical Care Improvement Project – CMS considering appropriate VTE prophylaxis to be a pay-forperformance quality measure for specific procedures

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Venous Thromboembolism Following Travel

International travel has become increasingly common and accessible, hence, about two billion passengers undertake international and domestic air travel each year. Venous thromboembolism (VTE) is a serious public health disorder which may occur following prolonged travel, especially after air travel. A direct relation between VTE development and prolonged travels has been documented, while some ...

متن کامل

Comparison of Efficacy and Safety of Two Different Enoxaparin Products in Prevention of Venous Thromboembolism Following Major Obstetric-gynecological Surgeries: An Open-label Randomized Clinical Trial

Venous thromboembolism (VTE) occurs in about 5 percent of patients undergoing major abdominal surgeries. Prophylaxis of VTE is recommended using unfractionated heparin (UF) or low molecular weight heparin (LMWH) in high-risk patients. In spite of advantages and confirmed cost-effectiveness of LMWH, high costs of enoxaparin branded preparations limit its use. We aimed to compare the efficacy and...

متن کامل

همراهی بین پلی‌مورفیسم‌های هموزیگوت‌ متیلن تتراهیدروفولات ردوکتاز و آنتی‌ژن PLA2 پلاکتی با ترومبوآمبولی وریدی (VTE) در شهرکرد

  B. Pourgheysari[1][2], A. Hasheminia[3], H. Rouhi-Boroujeni3   Received: 20/02/2014 Sent for Revision: 22/01/2014 Received Revised Manuscript: 09/10/2012 Accepted: 28/07/2012   Background and Objective: Venous thromboembolism (VTE) is one of the main causes of mortality in different human communities. Factor V Leiden, MTHFR C677T polymorphism and PLA2 polymorphism of platele...

متن کامل

Comparison of Efficacy and Safety of Two Different Enoxaparin Products in Prevention of Venous Thromboembolism Following Major Obstetric-gynecological Surgeries: An Open-label Randomized Clinical Trial

Venous thromboembolism (VTE) occurs in about 5 percent of patients undergoing major abdominal surgeries. Prophylaxis of VTE is recommended using unfractionated heparin (UF) or low molecular weight heparin (LMWH) in high-risk patients. In spite of advantages and confirmed cost-effectiveness of LMWH, high costs of enoxaparin branded preparations limit its use. We aimed to compare the efficacy and...

متن کامل

Rivaroxaban versus enoxaparin for treatment of patients with nonhematologic cancer with venous thromboembolism a randomized clinial trial

Background: Low-Molecular-Weight Heparin (LMWH) is recommended as the first-line treatment in patients with active cancer and venous thromboembolism (VTE), but many patients prefer to take oral anticoagulants and non-injectable forms with more reasonable price. Venous thromboembolism is a very common comorbidity in patients with cancer. Therefore, the aim of this study was to evaluate the effic...

متن کامل

بررسی میزان استفاده از عوامل پیشگیری کننده ترومبوآمبولی وریدی در بخش جراحی یک بیمارستان خصوصی در تهران

ABSTRACT Venous thromboembolism (VTE) is one of the most common problems involves patients in a surgical ward. This problem will be preventable, if we consider risk factors in these patients and use preventive measurments on time. To evaluae our colleages in surgical ward for using preventive medications and physical methods in prevention of venous thromboembolism, we conducted this cr...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2014